ANS Pharmacology Flashcards

1
Q

neuropeptidergic

A

ANS neurotransmission pathways important physiologically but not so much clinically/pharmacologically

calcitonin gene-related peptide
vascular intestinal polypeptide
nitric oxide
tachykinins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

differences between cholinergic and adrenergic neurotransmission

A

cholinergic
- neurons produce, secrete, and/or respond to acetylcholine

adrenergic
- neurons produce, secrete, and/or respond to norepinephrine or epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

alpha 1 neurotransmitters

A

norepinephrine
- at physiologic levels

epinephrine

  • during fight/flight rxn
  • after high dose administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

alpha 2 neurotransmitters

A

norepinephrine and epinephrine

- both only at high doses (fight/flight, or administration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

beta 1 NTs

A

norepinephrine
- at physiologic levels

epinephrine
- at physiologic levels

isoproterenol
- beta specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

beta 2 NTs

A

norepinephrine
- at high levels

epinephrine
- at physiologic levels

isoproterenol
- beta specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

beta 3 NTs

A

norepinephrine

epinephrine

isoproterenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

alpha 1 mechanism

A

metabotropic

  • increase intracellular Ca
  • produce IP3 and DAG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

alpha 2 mechanism

A

metabotropic

  • inhibition of adenylyl cyclase
  • decrease cAMP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

beta mechanism

A

metabotropic

  • stimulate adenylyl cyclase
  • increase cAMP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

nicotinic mechanism

A

ionotropic

  • influx of cations
  • depolarization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

muscarinic mechanism

A

M1/M3/M5

  • coupled with Gq
  • stimulate phospholipase C
  • IP3 and DAG

M2/M4

  • coupled with Gi
  • inhibit adenylyl cyclase
  • decrease cAMP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

where are alpha 1 receptors found and what actions do they stimulate

A

primarily on the post-synaptic membrane

vascular smooth muscle
- contraction

pupillary dilator muscle
- contraction

heart
- increase force of contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

where are alpha 2 receptors found and what actions do they stimulate

A

pre-synaptic membrane
- auto-inhibition, dec. NT release

platelets
- aggregation

some vascular smooth muscle

  • *non-synaptic**
  • contraction

fat cells
- inhibit lipolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

where are beta 1 receptor found and what actions do they stimulate

A

heart
- increase rate and force of contraction

juxtoglomerular cells
- increase renin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

where are beta 2 receptors found and what actions do they stimulate

A

respiratory, uterine, and vascular smooth muscle
- relaxation

non-synaptic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

where are beta 3 receptors found and what actions do they stimulate

A

adipocytes

- lipolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

where are Nn receptors found and what actions do they stimulate

A

post-ganglionic ANS neurons

- excitatory

19
Q

where are Nm receptors found and what actions do they stimulate

A

skeletal muscle

- contraction

20
Q

what actions do muscarinic receptors stimulate

A

decrease the rate and force of cardiac contraction

facilitate smooth muscle contraction
- except in blood vessels muscarinic receptors cause dilation of BV (via NO stimulation effect on endothelial cells)

21
Q

describe blood vessels under physiologic NE release

A
  1. NE released from sympathetic nerves
  2. only innervates alpha 1 receptors (beta 2 are non-synaptic)
  3. alpha 1 stimulation causes contraction
  4. increase blood pressure
22
Q

describe blood vessels under fight/flight conditions

A
  1. epinephrine released in addition to physiologic NE
  2. binds beta 1 and beta 2 (only bind alpha at very high levels)
  3. skeletal muscle vessels (alpha and beta 2) will be slightly more dilated than the subcutaneous muscle vessels (only have alpha)
23
Q

predominant tone?

arterioles

A

sympathetic

24
Q

predominant tone?

heart

A

parasympathetic

25
predominant tone? bronchial smooth muscle
parasympathetic
26
predominant tone? GI and urinary tracts
parasympathetic
27
predominant tone? sweat glands
sympathetic
28
predominant tone? pilomotor muscles
sympathetic
29
describe cross-talk between sympathetic and parasympathetic neurons
sympathetic nerve terminal - alpha 2 receptors for auto-inhibition - M2 receptors for inhibition by parasympathetic Ach release parasympathetic nerve terminal - M2 receptors for auto-inhibition - alpha 2 or beta 2 receptors for inhibition by sympathetic NE release * *beta 2 effect varies (excitatory or inhibitory) between spp.
30
miosis control
contraction of sphincter muscles | - stimulated by parasympathetic muscarinic receptors
31
mydriasis control
contraction of radial muscles | - stimulated by sympathetic a1 receptors
32
identify 3 major differences between a1 and B2 control of blood vessel diameter
a1 - vasoconstriction - basically all vascular smooth muscle - synaptic B2 - vasodilation - smooth muscle of skeletal muscle vasculature - non-synaptic
33
antagonist mechanisms
1. prevent synthesis 2. prevent vesicle formation 3. prevent "docking" of the vesicle 4. stimulate auto-inhibitor receptors (i.e. a2) 5. accelerate breakdown of NT in cleft 6. increase uptake of NT from cleft 7. block post-synaptic receptors - competitive inhibition = direct antagonism
34
agonist mechanisms
1. increase 2nd messenger action 2. decrease NT degradation (i.e. inhibit AchE) 3. block reuptake of NT (cocaine, dopamine) 4. stimulate release of NT (black widow venom) 5. increase synthesis (i.e. L-dopa = precursor to dopamine) 6. stimulate post-synaptic receptors (direct agonist)
35
sympathomimetics
direct agonists of a1, B1, B2, a2 (post-synaptic) direct antagonists of pre-synpatic a2 indirect agonists
36
sympatholytics
direct antagonists of a1, B1, B2, a2 (post-synaptic) direct agonists of pre-synpatic a2 indirect antagonists
37
parasympathomimetics
direct agonists of Nn, Nm, or M direct antagonists of M2 (pre-synaptic) indirect agonists
38
NE synthetic pathway
tyrosine - tyrosine hydroxylase L-dopa dopamine - dopamine-beta-hydroxylase norepinephrine - phenylethanolamine N-methyltransferase epinephrine
39
how to AchE inhibitors vary
duration of action
40
why use sympathomimetics (7)
1. hypotension 2. anaphylaxis 3. urinary incontinence 4. nasal congestion 5. bradycardia 6. congestive heart failure / cardiac arrest 7. asthma
41
why use sympatholytics (3)
1. hypertension 2. glaucoma 3. congestive heart failure / cardiac arrest
42
if the heart fails because it has been working to hard, how do you treat
sympatholytics
43
why use parasympathomimetics (3)
1. glaucoma 2. GI stasis and urinary retention (in the absence of obstruction) 3. myasthenia gravis
44
why use parasympatholytics (6)
1. produce mydriasis *** 2. pre-anesthetic 3. GI hypermotility, GI spasms, urinary tract 4. antiemetic 5. urinary incontinence 6. OP toxicity Tx